EMIS Group

EMIS is a clinical software supplier to the primary, community and acute care markets in the UK and provides software to the community pharmacy market. Its Patient business provides medical and wellbeing information as well as transactional services to patients.

Equities

Equities by Sector

Sectors

Megatrends

Thematics

Latest

Edison explains: Weight-loss drugs – how are GLP-1s redistributing consumer spending?

Edison explains: Europe’s ageing buildings

Stock of the month – PZ Cussons

Audiovisual

Latest

The Metals Company – equity proposition

Vantage: Rockwood Strategic – UK small-cap value and active engagement

Bull, Bear & Beyond – Living REIT: executive interview

About Edison

Corporates

Investors

Careers

EMIS Group (AIM: EMIS)

Latest Insights

EMIS Group — Final regulatory approval received for takeover

EMIS Group — H123 on track; 21.3p interim dividend declared

EMIS Group — CMA provisionally clears takeover of EMIS

EMIS Group — FY22 results in line

Market Data

Sector

Research

EMIS Group FY21 results – executive interview

EMIS Group — Strong FY21 drives upgrades

EMIS Group — Supporting a more proactive health service

EMIS Group — Commercialising recent investment

EMIS Group – executive interview

EMIS Group — Returning to business as usual

EMIS Group — Back on the growth track

EMIS Group – executive interview

EMIS Group — Better performance in H220

EMIS Group — Balancing the near- and long-term view

EMIS GROUP – executive interview

EMIS Group — FY20 outlook maintained

EMIS Group — Supporting the fight against COVID-19

EMIS Group — Well positioned to weather the storm

Executive interview – EMIS Group

EMIS Group — On track

EMIS Group — Selected for IT Futures framework

EMIS Group — Making good progress on technology roadmap

Executive interview – EMIS Group

EMIS Group — Streamlined business on track

EMIS Group — Disposal of non-core eye-screening business

EMIS Group — Returning to innovative roots

Executive interview – EMIS

EMIS — FY18 trading in line

EMIS Group — Unveiling EMIS-X

EMIS Group — Acquiring blockchain expertise

EMIS Group — NO SUBTITLE

EMIS Group — Preparing for the next stage of growth

Executive Interview – EMIS Group

EMIS Group — Solid H1; on track to meet FY18 expectations

EMIS Group — GPSoC extension confirmed

EMIS Group — Strengthening the core

Executive interview – EMIS Group

EMIS Group — Loss of Welsh GP business

EMIS Group — Internal review uncovers support issue

EMIS Group — Maintaining profitability

Executive interview – EMIS Group

EMIS Group — Steady progress

EMIS Group — Strengthening its position despite NHS funding pressures

Executive Interview – EMIS Group

EMIS Group — Update 27 January 2017

EMIS Group — Update 15 September 2016

EMIS Group — Update 14 April 2016

Edison explains: The UK M&A paradox – why takeover activity is accelerating despite the macroeconomic backdrop

Edison explains: The picks and shovels of AI buildout – unlocking value in the upstream supply chain

Edison explains: The Iran war may have triggered the next global supply shock

Edison explains: The EIS and SEIS – the tax relief opportunity not enough investors are taking advantage of

Edison explains: The copper ceiling – can nickel soften the blow when the world’s most critical metal runs short?

Edison explains: Tokenised assets – could tokenisation reshape how investors access financial markets?

Edison explains: The cement challenge – can the world’s dirtiest building material go clean?

Edison explains: Critical social infrastructure – how to invest in the UK’s social impact REITs

Edison explains: AI slop – when fake news costs real money

Digital assets – Part 5: Digital asset treasury companies